BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition - PubMed (original) (raw)
. 2004 May 7;279(19):19643-8.
doi: 10.1074/jbc.M311780200. Epub 2004 Feb 27.
Affiliations
- PMID: 14990569
- DOI: 10.1074/jbc.M311780200
Free article
BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition
Mutsuko Ouchi et al. J Biol Chem. 2004.
Free article
Retraction in
- Retraction. BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition.
Ouchi M, Fujiuchi N, Sasai K, Katayama H, Minamishima YA, Ongusaha PP, Deng C, Sen S, Lee SW, Ouchi T. Ouchi M, et al. J Biol Chem. 2015 Sep 4;290(36):22311. doi: 10.1074/jbc.A115.311780. J Biol Chem. 2015. PMID: 26341884 Free PMC article. No abstract available.
Abstract
Aurora-A/BTAK/STK15 localizes to the centrosome in the G(2)-M phase, and its kinase activity regulates the G(2) to M transition of the cell cycle. Previous studies have shown that the BRCA1 breast cancer tumor suppressor also localizes to the centrosome and that BRCA1 inactivation results in loss of the G(2)-M checkpoint. We demonstrate here that Aurora-A physically binds to and phosphorylates BRCA1. Biochemical analysis showed that BRCA1 amino acids 1314-1863 binds to Aurora-A. Site-directed mutagenesis indicated that Ser(308) of BRCA1 is phosphorylated by Aurora-A in vitro. Anti-phospho-specific antibodies against Ser(308) of BRCA1 demonstrated that Ser(308) is phosphorylated in vivo. Phosphorylation of Ser(308) increased in the early M phase when Aurora-A activity also increases; these effects could be abolished by ionizing radiation. Consistent with these observations, acute loss of Aurora-A by small interfering RNA resulted in reduced phosphorylation of BRCA1 Ser(308), and transient infection of adenovirus Aurora-A increased Ser(308) phosphorylation. Mutation of a single phosphorylation site of BRCA1 (S308N), when expressed in BRCA1-deficient mouse embryo fibroblasts, decreased the number of cells in the M phase to a degree similar to that with wild type BRCA1-mediated G(2) arrest induced by DNA damage. We propose that BRCA1 phosphorylation by Aurora-A plays a role in G(2) to M transition of cell cycle.
Similar articles
- CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage.
Cazales M, Schmitt E, Montembault E, Dozier C, Prigent C, Ducommun B. Cazales M, et al. Cell Cycle. 2005 Sep;4(9):1233-8. doi: 10.4161/cc.4.9.1964. Epub 2005 Sep 23. Cell Cycle. 2005. PMID: 16082213 - Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control.
Lou Z, Chini CC, Minter-Dykhouse K, Chen J. Lou Z, et al. J Biol Chem. 2003 Apr 18;278(16):13599-602. doi: 10.1074/jbc.C300060200. Epub 2003 Feb 27. J Biol Chem. 2003. PMID: 12611903 - The role of Polo-like kinase 1 in the inhibition of centrosome separation after ionizing radiation.
Zhang W, Fletcher L, Muschel RJ. Zhang W, et al. J Biol Chem. 2005 Dec 30;280(52):42994-9. doi: 10.1074/jbc.M505450200. Epub 2005 Sep 12. J Biol Chem. 2005. PMID: 16157594 - The Aurora kinases: role in cell transformation and tumorigenesis.
Katayama H, Brinkley WR, Sen S. Katayama H, et al. Cancer Metastasis Rev. 2003 Dec;22(4):451-64. doi: 10.1023/a:1023789416385. Cancer Metastasis Rev. 2003. PMID: 12884918 Review. - Physiological and oncogenic Aurora-A pathway.
Saeki T, Ouchi M, Ouchi T. Saeki T, et al. Int J Biol Sci. 2009 Nov 26;5(7):758-62. doi: 10.7150/ijbs.5.758. Int J Biol Sci. 2009. PMID: 20011137 Free PMC article. Review.
Cited by
- Unlocking New Avenues in Breast Cancer Treatment: The Synergy of Kinase Inhibitors and Immunotherapy.
Bravo MJ, Burgos-Molina AM, García-Aranda M, Redondo M, Téllez T. Bravo MJ, et al. Cancers (Basel). 2023 Nov 21;15(23):5499. doi: 10.3390/cancers15235499. Cancers (Basel). 2023. PMID: 38067203 Free PMC article. Review. - The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.
Willems E, Lombard A, Dedobbeleer M, Goffart N, Rogister B. Willems E, et al. Target Oncol. 2017 Feb;12(1):11-18. doi: 10.1007/s11523-016-0457-2. Target Oncol. 2017. PMID: 27573024 Review. - Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.
Zhang YQ, Pilyugin M, Kuester D, Leoni VP, Li L, Casula G, Zorcolo L, Schneider-Stock R, Atzori L, Irminger-Finger I. Zhang YQ, et al. Br J Cancer. 2012 Aug 7;107(4):675-83. doi: 10.1038/bjc.2012.297. Epub 2012 Jul 19. Br J Cancer. 2012. PMID: 22814582 Free PMC article. - Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.
Yang G, Chang B, Yang F, Guo X, Cai KQ, Xiao XS, Wang H, Sen S, Hung MC, Mills GB, Chang S, Multani AS, Mercado-Uribe I, Liu J. Yang G, et al. Clin Cancer Res. 2010 Jun 15;16(12):3171-81. doi: 10.1158/1078-0432.CCR-09-3171. Epub 2010 Apr 27. Clin Cancer Res. 2010. PMID: 20423983 Free PMC article. - The aurora kinase A regulates GSK-3beta in gastric cancer cells.
Dar AA, Belkhiri A, El-Rifai W. Dar AA, et al. Oncogene. 2009 Feb 12;28(6):866-75. doi: 10.1038/onc.2008.434. Epub 2008 Dec 8. Oncogene. 2009. PMID: 19060929 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous